Add to ORKGefficacy, and safety of gabapentin, a new antiepileptic drug (AED). Gabapentin's potential role in the treatment of epilepsy also was assessed. DATASOURCE: A MEDLINE search was performed to identify all published literature (manuscripts and abstracts). Abstracts presente
Purpose: To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiep...
Introduction: Gabapentin is a drug used for monotherapy or adjunctive therapy of simple and complex ...
Despite recent advances in neurobiology and significant insight into the molecular dysfunction of ep...
Gabapentin is an antiepileptic drug (AED) by design expected to mimic the action of the neurotransmi...
US Food and Drug Administration (USFDA) approved gabapentin as an adjuvant treatment for refractory ...
Three new antiepileptic drugs (AEDs) are finding increasing use in medical practice. To examine thei...
Gabapentin, a relatively new anti-epileptic drug (liED), is emerging as a therapeutic option JOr tre...
ABSTRACT: Recently, there has been an increase in the research devoted to the study of investigation...
The results of three large, placebo-controlled, multicenter clinical trials of gabapentin as add-on ...
Antiepileptic drugs (AEDs) are central nervous system (CNS) agents that are prescribed in a number o...
Gabapentin (GBP) possesses a well documented clinical efficacy in those types of focal epilepsy othe...
Gabapentin enjoys a wide spectrum of psychop-harmacological and neuropharmacological indi-cations. C...
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a C...
Background: In recent years many AEDs are been prescribed for indications other than epilepsy. DUE d...
Clinical trials for the newer antiepileptic drugs (AEDs) have provided inconclusive information to e...
Purpose: To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiep...
Introduction: Gabapentin is a drug used for monotherapy or adjunctive therapy of simple and complex ...
Despite recent advances in neurobiology and significant insight into the molecular dysfunction of ep...
Gabapentin is an antiepileptic drug (AED) by design expected to mimic the action of the neurotransmi...
US Food and Drug Administration (USFDA) approved gabapentin as an adjuvant treatment for refractory ...
Three new antiepileptic drugs (AEDs) are finding increasing use in medical practice. To examine thei...
Gabapentin, a relatively new anti-epileptic drug (liED), is emerging as a therapeutic option JOr tre...
ABSTRACT: Recently, there has been an increase in the research devoted to the study of investigation...
The results of three large, placebo-controlled, multicenter clinical trials of gabapentin as add-on ...
Antiepileptic drugs (AEDs) are central nervous system (CNS) agents that are prescribed in a number o...
Gabapentin (GBP) possesses a well documented clinical efficacy in those types of focal epilepsy othe...
Gabapentin enjoys a wide spectrum of psychop-harmacological and neuropharmacological indi-cations. C...
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a C...
Background: In recent years many AEDs are been prescribed for indications other than epilepsy. DUE d...
Clinical trials for the newer antiepileptic drugs (AEDs) have provided inconclusive information to e...
Purpose: To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiep...
Introduction: Gabapentin is a drug used for monotherapy or adjunctive therapy of simple and complex ...
Despite recent advances in neurobiology and significant insight into the molecular dysfunction of ep...